Literature DB >> 21152982

Fulfilling Koch's postulates confirms the mycotic origin of Lethargic Crab Disease.

Raphael Orélis-Ribeiro1, Walter A Boeger, Vânia A Vicente, Marcelo Chammas, Antonio Ostrensky.   

Abstract

In the northeast region of the Brazilian coast, a disease has been causing massive mortalities of populations of the mangrove land crab, Ucides cordatus (L.) since 1997. The clinical signs of this disease, which include lethargy and ataxia, led to the disease being termed Lethargic Crab Disease (LCD). Evidence from a variety of sources indicates that there is an association between LCD and a new species of black yeast, Exophiala cancerae de Hoog, Vicente, Najafzadeh, Badali, Seyedmousavi & Boeger. This study tests this putative correlation through in vivo experiments. Disease-free specimens of U. cordatus were experimentally infected with Exophiala cancerae (strain CBS 120420) isolate. During the 30-day experimental period, only a single death was observed within the control crabs. However, at the end of this period, crabs that were inoculated once or three-times with mycelial elements and hyphae of E. cancerae had a 60% and 50% mortality rates, respectively (n = 6 and n = 5). These results support that the fungal agent is pathogenic and is the causative agent of LCD. Species-specific molecular markers confirm the presence of E. cancerae (strain CBS 120420) in recovered colonies and tissue samples from the infected animals. The experimentally infected crabs manifested signs (lethargy, ataxia and tetany) that were consistent to LCD-affected animals in the environment. These results fulfil Koch's postulates and the hypothesis that the tested strain of Exophiala cancerae is a causative agent of LCD is accepted.

Entities:  

Mesh:

Year:  2010        PMID: 21152982     DOI: 10.1007/s10482-010-9531-4

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


  6 in total

1.  Capture and commercialization of blue land crabs ("guaiamum") Cardisoma guanhumi (Lattreille, 1825) along the coast of Bahia State, Brazil: an ethnoecological approach.

Authors:  Angélica M S Firmo; Mônica M P Tognella; Saulo R Silva; Raynner R R D Barboza; Rômulo R N Alves
Journal:  J Ethnobiol Ethnomed       Date:  2012-03-19       Impact factor: 2.733

2.  Is Marine Dispersion of the Lethargic Crab Disease Possible? Assessing the Tolerance of Exophiala cancerae to a Broad Combination of Salinities, Temperatures, and Exposure Times.

Authors:  Raphael Orélis-Ribeiro; Vânia A Vicente; Antonio Ostrensky; Marcelo A Chammas; Walter A Boeger
Journal:  Mycopathologia       Date:  2017-06-28       Impact factor: 2.574

3.  Characterization and molecular epidemiology of a fungal infection of edible crabs (Cancer pagurus) and interaction of the fungus with the dinoflagellate parasite Hematodinium.

Authors:  Amanda L Smith; Kristina M Hamilton; Lucy Hirschle; Emma C Wootton; Claire L Vogan; Edward C Pope; Daniel C Eastwood; Andrew F Rowley
Journal:  Appl Environ Microbiol       Date:  2012-11-16       Impact factor: 4.792

4.  Perceptions of environmental changes and lethargic crab disease among crab harvesters in a Brazilian coastal community.

Authors:  Angélica M S Firmo; Mônica M P Tognella; Walter L O Có; Raynner R D Barboza; Rômulo R N Alves
Journal:  J Ethnobiol Ethnomed       Date:  2011-11-16       Impact factor: 2.733

5.  Black yeast biota in the mangrove, in search of the origin of the lethargic crab disease (LCD).

Authors:  Raquel Schier Guerra; Mariana Machado Fidelis do Nascimento; Stephanie Miesch; Mohammad Javad Najafzadeh; Raphael Orélis Ribeiro; Antonio Ostrensky; Gerrit Sybren de Hoog; Vania Aparecida Vicente; Walter A Boeger
Journal:  Mycopathologia       Date:  2013-03-29       Impact factor: 2.574

6.  Habits and customs of crab catchers in southern Bahia, Brazil.

Authors:  Angélica M S Firmo; Mônica M P Tognella; Gabrielle D Tenório; Raynner R D Barboza; Rômulo R N Alves
Journal:  J Ethnobiol Ethnomed       Date:  2017-08-23       Impact factor: 2.733

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.